
GC61863
Verucopeptin
Also known as (2S)-2-hydroxy-N-[(3S,4S,19R)-17-hydroxy-8,14-dimethyl-2,6,9,12,15,18-hexaoxo-4-propan-2-yl-5-oxa-1,8,11,14,17,23-hexazabicyclo[17.4.0]tricosan-3-yl]-2-[(5S,6R)-2-hydroxy-5-methoxy-6-[(E,4S,6S,8R)-4,6,8-trimethyldec-2-en-2-yl]oxan-2-yl]propanamide
Verucopeptin is a potent?HIF-1 (IC50=0·22 μM) inhibitor and decreases the expression of HIF-1 target genes and HIF-1α protein levels· Verucopeptin strongly inhibits v-ATPase activity?by directly targeting the v-ATPase ATP6V1G subunit but not ATP1V1B2 or ATP6V1D· Verucopeptin exhibits antitumor activity against multidrug resistance (MDR)?cancers and can be used for cancer research
- CAS number
- 138067-14-8
- Molecular weight
- 896.08
- Formula
- C43H73N7O13
- InChIKey
- IKTLLLGZSOKVRF-GWALSTOSSA-N
- Catalogue number
- GC61863
- Brand
- GLPBIO
Computed properties PubChem CID 121231434 · XLogP 3.1 · TPSA 257 Ų · H-bond donors 6
- XLogP
- 3.1
- TPSA
- 257 Ų
- H-bond donors
- 6
- H-bond acceptors
- 14
- Rotatable bonds
- 12
- Heavy atoms
- 63
SMILES CC[C@@H](C)C[C@H](C)C[C@H](C)/C=C(\C)/[C@@H]1[C@H](CCC(O1)([C@@](C)(C(=O)N[C@H]2[C@@H](OC(=O)CN(C(=O)CNC(=O)CN(C(=O)CN(C(=O)[C@H]3CCCNN3C2=O)O)C)C)C(C)C)O)O)OC
Computed descriptors from PubChem (CID 121231434), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il